BA.3.2 is distinct from its ancestral BA.3 in many aspects. It acquires four new N-linked glycosylation sites in the N-terminal domain (NTD) and receptor-binding domain (RBD) of spike; disruption of which enhances viral infectivity and restores sensitivity to nAbs.
journals.asm.org/eprint/CFS52...
Really honored to be named a 2026 Ohio State Distinguished University Professor. Thank you to my mentors, trainees, and collaborators for all the support and encouragement. faculty.osu.edu/news/2026/04...
Shan-Lu Liu
Shan-Lu Liu
Early bird registration for #ASV2026 ends tomorrow June 1! Get that meal prep done and don't forget to register.
www.asv.org/registration
ASV remembers Dr. J. Michael Bishop, a luminary in virology, upon his passing earlier this month.
Are you attending #ASV2026? The early bird registration deadline is just 15 days away. Register by June 1 for a discounted rate: na.eventscloud.com/ereg/index.p...
We are recruiting 1-2 postdoctoral fellows to investigate the specificity of human anti-influenza virus antibodies, and to determine how these antibodies impact global antigenic drift of influenza viruses.
Join our lab at Penn in Philly. Reach out if you are interested in applying! Please repost!
ASV is eager to assist early-career virologists who have lost their research funding but would like to attend #ASV2026 in Minneapolis. Please see more details here: asv.memberclicks.net/index.php?op...
Is this your first ASV? Check out this members only event to learn how to best navigate #ASV2026
